CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 353 enrolled
Drug / intervention
Rosuvastatin +2 moredrug
Likely dose
Rosuvastatin 10 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00296374
NCT00296374Phase 2Completed
CompareCT.gov

Randomised, Double-blind, 52-wk, Parallel-grp, Multicentre, PIIb Study to Evaluate Effects of Rosuvastatin 10mg, Rosuvastatin 40mg and Atorvastatin 80mg on Urinary Protein Excretion in Hypercholesterolaemic Diabetic Patients With Moderate Proteinuria

AstraZeneca·interventional·Posted Feb 27, 2006·Updated Sep 1, 2011

In Brief

A Phase 2 clinical trial evaluating Rosuvastatin and Atorvastatin for Diabetes Mellitus. Completed, enrolled 353 participants across 116 sites in 11 countries.

Detailed Summary

The purpose of this study is to evaluate the effects of Crestor (rosuvastatin) and (Lipitor) atorvastatin on urinary protein excretion over 1 year in patients with Type 1 or 2 diabetes with moderate proteinuria and hypercholesterolaemia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus
CountriesArgentina, Brazil, Bulgaria, Canada, Denmark, France, Hungary, Italy, Mexico, Romania, United States
Collaborators--

Timeline

Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 27, 2006
Enrollment StartFeb 1, 2006
Primary CompletionMar 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 20.3 years ago

Interventions

Rosuvastatindrug

10 mg oral dose administered once daily for 52 weeks

Rosuvastatindrug

20 mg oral dose administered once daily for 4 weeks followed by 40 mg oral dose administered once daily for 48 weeks

Atorvastatindrug

40 mg oral dose administered once daily for 4 weeks followed by 80 mg oral dose administered once daily for 48 weeks